You are here

Front > Search FHI 360

Search FHI 360

Start a New Search

Search within these results

195 Results Found

  • Publication

    Network: Hormonal Contraception and HIV

    2007 — Hormonal contraceptives are among the most popular and effective methods of family planning. But some studies have suggested that the use of these methods might be associated with an increased risk of acquiring HIV from an infected partner....
  • News

    FHI 360 statement on the Heffron et al study and hormonal contraceptives and HIV risk

    On October 4, 2011 The Lancet Infectious Diseases published an article by Renee Heffron and a group of researchers at the University of Washington. The study was conducted among nearly 3,800 HIV-serodiscordant couples (in which one partner is HIV...
  • Gregory S. Kopf, PhD
    Expert

    Gregory S. Kopf, PhD

    Director, Research and Development, Contraceptive Technology Innovation

  • News

    ECHO Study of hormonal contraception and HIV begins

    FHI 360 and partners embark on a landmark study designed to fill a critical gap in the scientific evidence on the relationship between HIV acquisition and hormonal contraceptives.
  • Project

    Development of a Biodegradable Implant for Contraception

    Funded by the Bill & Melinda Gates Foundation, FHI 360 is conducting preclinical work and a first-in- human study on a biodegradable contraceptive implant called Casea S.
  • Tools

    NORMAL Counseling Tool for Menstrual Bleeding Changes (job aid)

    This job aid contains guidance for health care providers to counsel family planning clients on bleeding changes associated with the use of hormonal contraception and the copper intrauterine device (IUD).
  • Publication

    Preventing Unintended Pregnancies and HIV

    September 2012 — The dramatic expansion of HIV prevention and treatment services has significantly reduced the incidence of HIV among children and improved maternal health. These achievements contribute directly to the health-related and...
  • Project

    LNG Long-Acting Microsphere Injectable Contraceptive

    Funded by the Bill & Melinda Gates Foundation, FHI 360 is developing a six-month levonorgestrel self-injectable contraceptive: the LNG long-acting microsphere injectable, or the LLMI.
  • Publication

    Implants Toolkit

    2015 — Hormonal implants consist of small, thin, flexible rods, each about the size of a matchstick, that contain levonorgestrel, a synthetic progesterone. They are a safe, highly effective and quickly reversible long-acting method that requires...
  • Laneta Dorflinger, PhD
    Expert

    Laneta Dorflinger, PhD

    Distinguished Scientist and Director, Contraceptive Technology Innovation